TABLE 1.
Sample | Concentration | Before treatment with NO |
After treatment with NO (∼530 μm)a |
|||||
---|---|---|---|---|---|---|---|---|
[4Fe-4S] | S2− | S2−/[4Fe-4S] | S2− | S2−/[4Fe-4S] | S0 | S0/[4Fe-4S] | ||
μm | μm | μm | μm | μm | ||||
1 | 37 | 33 | 134 (± 7) | 4.0 (± 0.2) | 7.6 (± 0.5) | 0.23 (± 0.01) | 76 (± 2) | 2.3 (± 0.1) |
2 | 39 | 35 | 139 (± 7) | 4.0 (± 0.2) | 24.5 (± 1.2) | 0.70 (± 0.04) | 50 (± 7) | 1.4 (± 0.2) |
3b | 26 | 23 | 92 (± 5) | 4.0 (± 0.2) | 17.6 (± 0.2) | 0.77 (± 0.10) | 43 (± 10) | 1.9 (± 0.4) |
a Samples had a final [NO]:[4Fe-4S] ratio of ∼15.
b Low molecular weight reactants and products were removed via gel filtration (PD10, GE Healthcare).